CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,096,127 | -26.8% | 26,965 | +17.6% | 0.18% | -22.0% |
| Q3 2022 | $1,498,000 | -7.8% | 22,920 | -14.3% | 0.23% | +58.7% |
| Q2 2022 | $1,625,000 | +204.9% | 26,738 | +214.6% | 0.14% | +210.9% |
| Q1 2022 | $533,000 | -39.8% | 8,499 | +7.5% | 0.05% | -28.1% |
| Q3 2021 | $885,000 | +9.1% | 7,906 | +49.2% | 0.06% | +16.4% |
| Q4 2020 | $811,000 | +243.6% | 5,300 | +64.9% | 0.06% | +243.8% |
| Q2 2020 | $236,000 | – | 3,215 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |